Publications by authors named "Marie A D Haverkort"

Claim this Profile
A
Age-related differences in patient preferences for adjuvant chemotherapy for high-risk endometrial cancer.
Famke C Wakkerman, Cathalijne C B Post, Jan Willem M Mens, Ina M Jürgenliemk-Schulz, Friederike L A Koppe, Marie A D Haverkort

Maturitas· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distant Metastasis After Chemoradiation and Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer.
Johannes Knoth, Remi A Nout, Richard Pötter, Umesh Mahantshetty, Ina Jürgenliemk-Schulz, Marie A D Haverkort

Int J Radiat Oncol Biol Phys· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma: Histologic and Clinicopathological Correlates.
Ezgi Dicle Serbes, Nanda Horeweg, Carlos Parra-Herran, Renske van Rijnsoever, Jan J Jobsen, Marie A D Haverkort

Mod Pathol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of a nurse-led sexual rehabilitation intervention for women treated with radiotherapy for gynaecological cancer in a randomized trial.
Isabelle Suvaal, Wilbert B van den Hout, Susanna B Hummel, Jan-Willem M Mens, Charlotte C Tuijnman-Raasveld, Marie A D Haverkort

Radiother Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a nurse-led sexual rehabilitation intervention for women with gynaecological cancers receiving radiotherapy: results of a randomised trial.
Isabelle Suvaal, Susanna B Hummel, Jan-Willem M Mens, Charlotte C Tuijnman-Raasveld, Roula Tsonaka, Marie A D Haverkort

Br J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials.
Famke C Wakkerman, Jiqing Wu, Hein Putter, Ina M Jürgenliemk-Schulz, Jan J Jobsen, Marie A D Haverkort

Lancet Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation.
Merve Kaya, Cathalijne C B Post, Carli M Tops, Maartje Nielsen, Emma J Crosbie, Marie A D Haverkort

Mod Pathol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas.
Amy Jamieson, Lisa Vermij, Claire J H Kramer, Jan J Jobsen, Ina Jürgemlienk-Schulz, Marie A D Haverkort

Clin Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer.
Nanda Horeweg, Remi A Nout, Ina M Jürgenliemk-Schulz, Ludy C H W Lutgens, Jan J Jobsen, Marie A D Haverkort

J Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
:
: A Quick, Simple, and Cheap Alternative for Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction.
Anne Sophie V M Van den Heerik, Natalja T Ter Haar, Lisa Vermij, Jan J Jobsen, Mariel Brinkhuis, Marie A D Haverkort

JCO Glob Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making.
Cathalijne C B Post, Jan Willem M Mens, Marie A D Haverkort, Friederike Koppe, Ina M Jürgenliemk-Schulz

Gynecol Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo dosimetry in gynecological applications-A feasibility study.
Marion P R Van Gellekom, Richard A M Canters, Frank J W M Dankers, Agnes Loopstra, Elzbieta M van der Steen-Banasik, Marie A D Haverkort

Brachytherapy· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive margin radiotherapy for patients with prostate carcinoma: what's the benefit?
Marie A D Haverkort, Jeroen B van de Kamer, Bradley R Pieters, Caro C E Koning, Marcel van Herk

Radiother Oncol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Position verification for the prostate: effect on rectal wall dose.
Marie A D Haverkort, Jeroen B van de Kamer, Bradley R Pieters, Geertjan van Tienhoven, Esther Assendelft

Int J Radiat Oncol Biol Phys· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis